|
| |
| | | 70617 | | 13.05.2026 | | Advanz Pharma Specialty Medicine Switzerland GmbH | | | | | | | 12.05.2031 | | | | | | 110000. | | | | 11.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Mynzepli 40 mg/ml | Injektionslösung in einer Fertigspritze | Injection solution in prefilled syringe (Afliberceptum 2mg / 0.05ml) | S01LA05 | |
|
|
|
